Infective endocarditis in HIV-infected patients


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

The analysis of literature data characterizing the prevalence, etiology, clinical course, localization of valvular injury, complications, diagnosis, treatment, prognosis and outcomes of infective endocarditis (IE) in various stages of HIV infection are presented. Aspects of tactics of management of patients with IE on the background of HIV infection, including those in the AIDS stage, are discussed: the features of drug therapy, indications for cardiac surgery. Further research is needed on various aspects of IE in the setting of HIV infection in order to improve diagnosis and prognosis. Effective interdisciplinary interaction of specialists (cardiologists, cardiac surgeons, infectious disease specialists) makes it possible to achieve in many cases the cure of valvular infection, reduction of viral load and restoration of cellular immunity, ensuring in the future a satisfactory quality of life for patients with infective endocarditis against the background of HIV infection.

Texto integral

Acesso é fechado

Sobre autores

Elena Ponomareva

V.I. Razumovsky Saratov State Medical University of the Ministry of Healthcare of Russia

Email: ponomareva_elena1@mail.ru
PhD, associate professor of the Department of hospital therapy of the Faculty of medicine

Andrey Rebrov

V.I. Razumovsky Saratov State Medical University of the Ministry of Healthcare of Russia

Email: andreyrebrov@yandex.ru
MD, professor, head of the Department of hospital therapy of the Faculty of medicine

Bibliografia

  1. Cosyns B., Motoc A., Arregle F., Habib G. A plea not to forget infective endocarditis in COVID-19 era. JACC Cardiovasc Imaging. 2020; 13(11): 2470-71. doi: 10.1016/j.jcmg.2020.07.027.
  2. Тюрин В.П. Инфекционные эндокардиты. 2-е издание, дополненное и переработанное. М.: ГЭОТАР-Медиа. 2013; 368 с. [Tyurin V.P. Infective endocarditis. 2nd edition, supplemented and revised. M.: GEOTAR-Media. 2013; 368 pp. (In Russ.)]. ISBN: 978-5-97042554-1, 978-5-9704-2080-5.
  3. Habib G., Lancellotti P., Manuel J. et al. 2015 ESC Guidelines for the management of infective endocarditis. The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J. 2015; 36(44): 3075-128. doi: 10.1093/ eurheartj/ehv319.
  4. Holland T.L., Baddour L.M., Bayer A.S. et al. Infective endocarditis. Nat Rev Dis Primers. 2016; 2: 16059. doi: 10.1038/nrdp.2016.59.
  5. Бартлетт Дж., Галлант Дж., Фам П. Клинические аспекты ВИЧ-инфекции. М.: Р.Валент. 2012; 528 с. [Bartlett J., Gallant J., Fam P. Clinical aspects of HIV infection. Moscow: R.Valent. 2012; 528 pp. (In Russ.)]. ISBN: 978-5-93439-409-8.
  6. Fisher C., Faselis C., Levy J. Medical USMLE Step 2 CK Internal Medicine: Lecture Notes. Kaplan. 2017; 257 pp. ASIN: DB009NHA88K.
  7. Федеральный научно-методический Центр по профилактике и борьбе со СПИДом. Количество ВИЧ-инфицированных в России. Доступ: http://www.hivrussia.ru (дата обращения - 22.02.2021).
  8. Покровский В.В., Ладная Н.Н., Покровская А.В. ВИЧ/СПИД сокращает число россиян и продолжительность их жизни. Демографическое обозрение. 2017; 1: 65-82.
  9. Lumsden R.H., Bloomfield G.S. The causes of HIV-associated cardiomyopathy: A tale of two worlds. Biomed Res Int. 2016; 2016: 8196560. doi: 10.1155/2016/8196560.
  10. Sousa C., Botelho C., Rodrigues D. et al. Infective endocarditis in intravenous drug abusers: An update. Eur J. Clin Microbiol Infect Dis. 2012; 31(11): 2905-10. doi: 10.1007/s10096-012-1675-x.
  11. Munoz-Moreno M.F., Ryan P., Alvaro-Meca A. et al. National temporal trend analysis of infective endocarditis among patients infected with HIV in Spain (1997-2014): A retrospective study. J. Clin Med. 2019; 8(8): 1167. doi: 10.3390/jcm8081167.
  12. Khayata M., Tashtish N., Al-Kindi S. et al. Infective endocarditis in patients with HIV: Analysis from the national inpatient sample. Circulation. 2019; 140: A13957.
  13. Taramasso L., Tatarelli P., Di Biagio A. Bloodstream infections in HIV-infected patients. Virulence. 2016; 7(3): 320-28. doi: 10.1080/21505594.2016.1158359.
  14. Mocroft A., Furrer H.J., Miro J.M. et al. The incidence of AIDS-defining illnesses at a current CD4 count s200 cells/pL in the postcombination antiretroviral therapy era. Clin Infect Dis. 2013; 57(7): 1038-47. doi: 10.1093/cid/cit423.
  15. Пономарева Е.Ю., Рощина А.А., Ребров А.П. Особенности течения инфекционного эндокардита на фоне ВИЧ/СПИДа у инъекционных наркоманов. Клиницист. 2011; 3: 19-22. doi: https://doi.org/10.17650/1818-8338-2011-3-19-22.
  16. Manga P., McCutcheon K., Tsabedze N. et al. HIV and nonischemic heart disease. J. Am Coll Cardiol. 2017; 69(1): 83-91. doi: 10.1016/j. jacc.2016.09.977.
  17. Голышко В.С., Снежицкий В.А., Матиевская Н.В., Савицкий С.Э. Патология сердечно-сосудистой системы у пациентов с впервые диагностированной ВИЧ-инфекцией (клинические случаи). Журнал Гродненского государственного медицинского университета. 2017; 4: 458-462. doi: https://doi.org/10.25298/2221-8785-2017-15-4-458-462.
  18. Столбова М.В., Лискова Ю.В., Артемова Н.Э. с соавт. Особенности инфекционного эндокардита у инъекционных «солевых» наркоманов. Архивъ внутренней медицины. 2017; 4: 267-270. doi: https://doi.org/10.20514/2226-6704-2017-7-4-267-270.
  19. Vasudev R., Shah P., Bikkina M., Shamoon F. Infective endocarditis in HIV. Int J. Cardiol. 2016; 214: 216-17. doi: 10.1016/j. ijcard.2016.03.125.
  20. Lorson W.C., Heidel R.E., Shorman M.A. Microbial epidemiology of infectious endocarditis in the intravenous drug abuse population: A retrospective study. Infect Dis Ther. 2019; 8(1): 113-18. doi: 10.1007/s40121-019-0232-7.
  21. Losa J.E., Miro J.M., Del Rio A. et al. Infective endocarditis not related to intravenous drug abuse in HIV-1-infected patients: report of eight cases and review of the literature. Clin Microbiol Infect. 2003; 9(1): 45-54. doi: 10.1046/j.1469-0691.2003.00505.x.
  22. Gebo K.A., Burkey M.D., Lucas G.M. et al. Incidence of risk factors for, clinical presentation, and 1-year outcomes of infective endocarditis in an urban HIV cohort. J. Acquir Immune Defic Syndr. 2006; 43(4): 426-32. doi: 10.1097/01.qai.0000243120.67529.78.
  23. Vogkou C.T., Vlachogiannis N.I., Palaiodimos L., Kousoulis A.A. The causative agents in infective endocarditis: A systematic review comprising 33,214 cases. Eur J. Clin Microbiol Infect Dis. 2016; 35(8): 1227-45. doi: 10.1007/s10096-016-2660-6.
  24. Munoz P., Kestler M., De Alarcon A. et al. Current epidemiology and outcome of infective endocarditis: A multicenter, prospective, cohort study. Medicine. 2015; 94(43): e1816. doi: 10.1097/MD.0000000000001816.
  25. Fishbein G.A., Fishbein M.C. Tricuspid and pulmonic valve pathology. Curr Cardiol Rep. 2019; 21(7): 54. doi: 10.1007/s11886-019-1143-7.
  26. Polanco A., Itagaki S., Chiang Y., Chikwe J. Changing prevalence, profile, and outcomes of patients with HIV undergoing cardiac surgery in the United States. Am Heart J. 2014; 167(3): 363-68. doi: 10.1016/j.ahj.2013.09.021.
  27. Rodger L., Glockler-Lauf S.D., Shojaei E. et al. Clinical characteristics and factors associated with mortality in first-episode infective endocarditis among persons who inject drugs. JAMA Network Open. 2018; 1(7): e185220. doi: 10.1001/jamanetworkopen.2018.5220.
  28. Пономарева Е.Ю., Елисеева С.П., Седов Д.С. Инфекционный эндокардит у больных ВИЧ/СПИДом: клинические наблюдения. Сердце: журнал для практикующих врачей. 2017; 4: 306-308.
  29. Пономарева Е.Ю., Тяпкина М.А., Ребров А.П. Поражение почек при инфекционном эндокардите у потребителей инъекционных наркотиков: клинические особенности и тубуло-интерстициальные нарушения. Клиническая нефрология. 2013; 4: 38-42.
  30. Bogorodskaya M., Chow F.C., Triant V.A. Stroke in HIV. Can J. Cardiol. 2019; 35(3): 280-87. doi: 10.1016/j.cjca.2018.11.032.
  31. Cecchi E., Imazio M., Tidu M. et al. Infective endocarditis in drug addicts: role of HIV infection and the diagnostic accuracy of Duke criteria. J. Cardiovasc Med (Hagerstown). 2007; 8(3): 169-75. doi: 10.2459/01.JCM.0000260824.14596.86.
  32. Nel S.H., Naidoo D.P. An echocardiographic study of infective endocarditis, with special reference to patients with HIV. Cardiovasc J. Afr. 2014; 25(2): 50-57. doi: 10.5830/CVJA-2013-084.
  33. Чипигина Н.С., Карпова Н.Ю., Белова М.В., Савилов Н.П. Инфекционный эндокардит: трудности диагностики. Клиницист. 2020; 14(1-2): 82-90. doi: https://dx.doi.org/10.17650/1818-8338-2020-14-1-2-82-90.
  34. Chin C.A., Guo L. Intramural abscesses: A sequela of infective endocarditis in a patient with HIV. J. Case Rep Stud. 2016; 4(4): 403.
  35. Tsabedze N., Vachiat A., Zachariah, D., Manga P. A new face of cardiac emergencies: Human immunodeficiency virus-related cardiac disease. Cardiol Clin. 2018; 36(1): 161-70. doi: 10.1016/j.ccl.2017.09.005.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Declaração de direitos autorais © Bionika Media, 2021

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies